Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinicopathologic Features of Breast Carcinomas Classified by Biomarkers and Correlation with Microvessel Density and VEGF Expression: A Study from Thailand

  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: To correlate breast cancer subtypes with prognostic factors, microvessel density (MVD), vascular endothelial growth factor (VEGF) expression and clinical features. Materials and Methods: One hundred cases of primary breast carcinoma were classified using biomarkers on tissue microarray as: luminal A [estrogen receptor (ER)+, HER2-, $Ki-67{\leq}14%$], luminal B [ER+, HER2+ or ER+, HER2-, Ki-67>14%], HER2, triple negative basal-like (TNB) [any basal cytokeratins (CKs, 5, 14, 17) and/or endothelial growth factor receptor (EGFR) expression], and TN without such markers [TNN, null], and assessed for p53, vimentin, VEGF and CD31 immunoperoxidase. Results: Of the 100 cases (mean age, 51 years; mean tumor size, 3.2cm; 56% with nodal metastasis; 89 invasive ductal carcinomas, not otherwise specified, 4 invasive lobular carcinomas, 3 metaplastic carcinomas, and 4 other types) there were 39 luminal A, 18 luminal B, 18 HER2, 15 TNB and 10 TNN. The positivities of basal-like markers in the basal-like subtype were 78.3% for CK5, 40% for CK14, 20% for CK17, 46.7% for EGFR. There was no significant difference in age distribution, tumor size, degree of tubular formation, pleomorphism, lymphovascular invasion, nodal metastasis, MVD, VEGF expression and survival among subgroups. TNs demonstrated significantly higher tumor grade, mitotic count, Ki-67 index, p53 and vimentin and decreased overall survival compared with nonTN. Conclusions: The distribution of breast cancer subtypes in this study was similar to other Asian countries with a high prevalence of TN. The high grade character of TN was confirmed and CK5 expression was found to be common in our basal-like subtype. No significant elevation of MVD or VEGF expression was apparent.

Keywords

References

  1. Carey LA, Perou CM, Livasy CA, et al (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 295, 2492-502. https://doi.org/10.1001/jama.295.21.2492
  2. Chaiwun B, Nakrungsee S, Sukhamwang N, Srisukho S (2010). A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study. Breast Cancer, 17, 35-41. https://doi.org/10.1007/s12282-009-0174-0
  3. Chuthapisith S, Permsapaya W, Warnnissorn M, et al (2012). Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. Asian Pac J Cancer Prev, 13, 459-62. https://doi.org/10.7314/APJCP.2012.13.2.459
  4. Dent R, Trudeau M, Pritchard KI, et al (2007). Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 13, 4429-34. https://doi.org/10.1158/1078-0432.CCR-06-3045
  5. Foulkes WD, Stefansson IM, Chappuis PO, et al (2003). Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst, 95, 1482-5. https://doi.org/10.1093/jnci/djg050
  6. Goldhirsch A, Wood WC, Coates AS, et al (2011). Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol, 22, 1736-47. https://doi.org/10.1093/annonc/mdr304
  7. Han W, Nicolau M, Noh DY, Jeffrey SS (2010). Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct population. Int J Oncol, 37, 51-9.
  8. Irvin WJ Jr, Carey LA (2008). What is triple-negative breast cancer? Eur J Cancer, 44, 2799-805. https://doi.org/10.1016/j.ejca.2008.09.034
  9. Jumppanen M, Gruvberger-Saal S, Kauraniemi P, et al (2007). Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. Breast Cancer Res, 9, 16.
  10. Kim MJ, Ro JY, Ahn S H, et al (2006). Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol, 37, 1217-26. https://doi.org/10.1016/j.humpath.2006.04.015
  11. Liu Y, Tamimi RM, Collins LC, et al (2011). The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. Breast Cancer Res Treat, 129, 175-84. https://doi.org/10.1007/s10549-011-1432-3
  12. Livasy CA, Karaca G, Nanda R, et al (2006). Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol, 19, 264-71. https://doi.org/10.1038/modpathol.3800528
  13. Lopes N, Sousa B, Vieira D, Milanezi F, Schmitt F (2009). Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles. Histopathology, 55, 594-9. https://doi.org/10.1111/j.1365-2559.2009.03417.x
  14. Nielsen TO, Hsu FD, Jensen K, et al (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 10, 5367-74. https://doi.org/10.1158/1078-0432.CCR-04-0220
  15. Perou CM, Sorlie T, Eisen MB, et al (2000). Molecular portraits of human breast tumours. Nature, 406, 747-52. https://doi.org/10.1038/35021093
  16. Reis-Filho JS, Tutt AN (2008). Triple negative tumours: a critical review. Histopathology, 52, 108-18.
  17. Ribeiro-Silva A, Ribeiro do Vale F, Zucoloto S (2006). Vascular endothelial growth factor expression in the basal subtype of breast carcinoma. Am J Clin Pathol, 125, 512-8. https://doi.org/10.1309/D744C4NM15J3B00D
  18. Sa-Nguanraksa D, Chuangsuwanich T, Pongpruttipan T, et al (2013). Vascular endothelial growth factor 634G/C polymorphism is associated with increased breast cancer risk and aggressiveness. Mol Med Rep, 8, 1242-50.
  19. Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74. https://doi.org/10.1073/pnas.191367098
  20. Sotiriou C, Neo SY, McShane LM, et al (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA, 100, 10393-8. https://doi.org/10.1073/pnas.1732912100
  21. Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A (2009). Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol, 20, 628-35. https://doi.org/10.1093/annonc/mdn675
  22. Taliano RJ, Lu S, Singh K et al (2013). Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis. Hum Pathol, 44, 2743-50. https://doi.org/10.1016/j.humpath.2013.07.021
  23. Tan GH, Taib NA, Choo WY, Teo SH, Yip CH (2009). Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country. Asian Pac J Cancer Prev, 10, 395-8.
  24. Thike AA, Cheok PY, Jara-Lazaro AR, et al (2010). Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol, 23, 123-33. https://doi.org/10.1038/modpathol.2009.145
  25. Yang W, Klos K, Yang Y, et al (2002). ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer, 94, 2855-61. https://doi.org/10.1002/cncr.10553

Cited by

  1. Survival Time and Molecular Subtypes of Breast Cancer after Radiotherapy in Thailand vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10505
  2. Expression of cluster of differentiation�34 and vascular endothelial growth factor in breast cancer, and their prognostic significance pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3348
  3. Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer vol.11, pp.1, 2016, https://doi.org/10.1371/journal.pone.0146823
  4. Relationship between HER2 Proto-oncogene Status and Prognostic Factors of Breast Cancer in the West of Iran vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.295